Plus Therapeutics (PSTV) Finished Goods (2011 - 2019)

Plus Therapeutics (PSTV) has 9 years of Finished Goods data on file, last reported at $1.7 million in Q1 2019.

• Finished Goods for Q1 2019 came in at $1.7 million, down 13.33% year-over-year; the trailing twelve-month figure through Mar 2019 was $1.7 million (down 13.33% YoY), and the FY2018 annual result was $1.6 million, down 8.2% from the prior year.
• Finished Goods advanced to $1.7 million in Q1 2019 per PSTV's latest filing, from $1.6 million in the prior quarter.
• Over five years, Finished Goods peaked at $2.5 million in Q4 2015 and troughed at $1.5 million in Q1 2015.
• A 5-year average of $1.9 million and a median of $1.8 million in 2017 frame the typical range for Finished Goods.
• The sharpest annual moves came in 2015 and 2016: Finished Goods slumped 33.92% in 2015, then jumped 50.79% in 2016.
• A 5-year view of Finished Goods shows it stood at $2.5 million in 2015, then fell by 26.45% to $1.8 million in 2016, then slipped by 2.14% to $1.8 million in 2017, then retreated by 8.2% to $1.6 million in 2018, then climbed by 2.69% to $1.7 million in 2019.
• Business Quant data shows PSTV's Finished Goods at $1.7 million in Q1 2019, $1.6 million in Q4 2018, and $1.7 million in Q3 2018.